ARKG Holdings of BEAM
Beam Therapeutics
BEAM Therapeutics is a biotechnology company focused on developing precision genetic medicines using base editing technology to treat various serious diseases at the molecular level. The company generates revenue through partnerships, collaborations, and potential future commercialization of its innovative therapies.
Trades of BEAM in ARKG
The ten most recent trades of Beam Therapeutics in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Dec 18, 2024 | Buy | $436,348 | 0.91% | 0.04% |
| Dec 17, 2024 | Buy | $364,812 | 0.72% | 0.03% |
| Dec 16, 2024 | Buy | $147,539 | 0.30% | 0.01% |
| Dec 13, 2024 | Buy | $131,281 | 0.27% | 0.01% |
| Nov 18, 2024 | Buy | $346,134 | 0.83% | 0.03% |
| Nov 15, 2024 | Buy | $842,860 | 2.00% | 0.07% |
| Aug 14, 2024 | Sell | $4,408 | 0.01% | 0.00% |
| Aug 13, 2024 | Sell | $42,722 | 0.11% | 0.00% |
| Aug 12, 2024 | Sell | $102,489 | 0.25% | 0.01% |
| Aug 09, 2024 | Sell | $50,429 | 0.12% | 0.00% |